NHS Pharmaceuticals Products Transition 2017_1
key details
| Value | £40,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West |
| Deadline | 13 Dec 2016 |
| Contract start | 1 May 2017 |
| Contract end | 30 Jun 2018 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-bcbf55b3-a27f-4459-b9da-6661b24458ef |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| See attachments for list of awarded suppliers | £40,000,000 | 23 Feb 2017 | active |
description
NHS Pharmaceuticals 2017_1
Offer reference number: CM/PHG/15/5490
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months Potential periods of call-offs under the framework agreement:
North West & Eastern & North London: 01/05/2017 to 31/01/2018 (9 months)
South East & South London & North East & Yorkshire: 01/05/2017 to 31/10/2017 (6 months)
Central & South West: 01/05/2017 to 30/06/2018 (14 months)
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 21 Apr 2017 | Award (award) | · | d6ca4e03-300f-48ee-b64f-a1ebf2a4b689-143229 |
more from Commercial Medicines Unit
- Antivirals for use in an influenza pandemic, or wide scale epidemic · 13 Oct 2017
- NHS Pharmaceutical Products · £155,000,000 · 31 Jan 2017
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.